معرفی
Mikko Airavaara is a Professor at the Department of Pharmacology and Drug Therapy within the University of Helsinki's Institute of Sustainability Science (HELSUS). He serves as a supervisor in the Doctoral Programme in Brain & Mind and Drug Research, focusing on neuropharmacology, gene therapy, and personalized medicine.
- Academic Rank: Professor
- University: University of Helsinki
- School: Institute of Sustainability Science (HELSUS)
- Department: Department of Pharmacology and Drug Therapy
Research Interests: His work spans Pharmacy, Neurosciences, and Drug Research, with recent studies on gene replacement strategies for neurodegenerative diseases, GDNF signaling in behavioral neuroscience, and proteasome activation for Parkinson's therapy. He also investigates mitochondrial dysfunction and drug interactions in stroke and metabolic disorders.
Scientific Awards:
- Innoopeli Prize (2022): Recognizing innovative research in drug development.
Grants & Projects: Currently leads projects funded by the Academy of Finland (PROFI program), Finnish Parkinson Foundation, and Juselius Foundation, focusing on neurodegenerative therapies and transporter pharmacogenomics.
